Evaluating Aspirin Plus Rivaroxaban versus Rivaroxaban Alone to Prevent Venous Stent Thrombosis in Post-Thrombotic Syndrome: Insights from the ARIVA Trial
Posted inClinical Updates Wellness & Lifestyle

Evaluating Aspirin Plus Rivaroxaban versus Rivaroxaban Alone to Prevent Venous Stent Thrombosis in Post-Thrombotic Syndrome: Insights from the ARIVA Trial

The ARIVA trial found no superior benefit of adding aspirin to rivaroxaban over rivaroxaban alone in preventing venous stent thrombosis within 6 months post-intervention in post-thrombotic syndrome patients, with both regimens showing high patency and safety.
Impact of Red Blood Cell Transfusion Strategies on Outcomes in Acute Myocardial Infarction Patients Undergoing Revascularization: Insights from the MINT Trial
Posted inClinical Updates Wellness & Lifestyle

Impact of Red Blood Cell Transfusion Strategies on Outcomes in Acute Myocardial Infarction Patients Undergoing Revascularization: Insights from the MINT Trial

This prespecified analysis of the MINT trial evaluates how liberal versus restrictive red blood cell transfusion strategies affect 30-day outcomes in acute MI patients, focusing on those undergoing revascularization, revealing nuanced risk profiles for cardiac death based on revascularization status.
AI-Driven Quantitative CT Reveals Higher Relative Cardiovascular Risk from Coronary Plaque in Women: Insights from the CONFIRM2 Registry
Posted inClinical Updates Wellness & Lifestyle

AI-Driven Quantitative CT Reveals Higher Relative Cardiovascular Risk from Coronary Plaque in Women: Insights from the CONFIRM2 Registry

AI-based quantitative CT analysis demonstrates that coronary plaque features, while more prevalent in men, confer a disproportionately higher relative risk of major adverse cardiovascular events in women, highlighting the need for sex-specific risk assessment and targeted interventions.